Search Results

You are looking at 1 - 10 of 36 items for :

  • "carcinoids" x
Clear All
Open access

Myrtille Fouché, Yves Bouffard, Mary-Charlotte Le Goff, Johanne Prothet, François Malavieille, Pierre Sagnard, Françoise Christin, Davy Hayi-Slayman, Arnaud Pasquer, Gilles Poncet, Thomas Walter and Thomas Rimmelé

Introduction Small-bowel neuroendocrine tumours (SB-NETs) are rare secreting neoplasms. Hormones (serotonin, histamine, bradykinin, prostaglandins and chromogranin-A) released into the systemic circulation can lead to a carcinoid syndrome (CS

Open access

Samira M Sadowski, Emanuel Christ, Benoit Bédat, Attila Kollár, Wolfram Karenovics, Aurel Perren, Frédéric Triponez and on behalf of the SwissNET registry

Introduction Neuroendocrine tumors of the lungs (LNET) represent approximately 30% of all NET ( 1 , 2 ) and account for 1–2% of all lung tumors. Lung NETs are classified into typical carcinoid (TC, low-grade tumors) and atypical carcinoid (AC

Open access

Irvin M Modlin, Harry Aslanian, Lisa Bodei, Ignat Drozdov and Mark Kidd

they comprise a heterogeneous group of cancers. Thus, tumor types range from histamine-secreting gastric ‘carcinoids’ to a mélange of pancreatic lesions (secreting glucagon, insulin, somatostatin, or vasoactive polypeptide – colloquially known as islet

Open access

Merete Gedde-Dahl, Espen Thiis-Evensen, Andreas Myklebust Tjølsen, Kjerstin Skrede Mordal, Morten Vatn and Deidi S Bergestuen

with endocrine functions (1) . Small intestinal NETs often produce vasoactive substances that may result in the carcinoid syndrome, symptoms of which include flushing, diarrhea, carcinoid heart disease, and bronchospasm. The syndrome is almost

Open access

Katherine Van Loon, Li Zhang, Jennifer Keiser, Cendy Carrasco, Katherine Glass, Maria-Teresa Ramirez, Sarah Bobiak, Eric K Nakakura, Alan P Venook, Manisha H Shah and Emily K Bergsland

(2) . Historically, bone metastases from NETs were considered to be extremely rare (3, 4) . As few as 50 case reports were identified in a recently published literature review on skeletal metastases from carcinoid tumors (5) . In a series of 145

Open access

Roxanne C S van Adrichem, Aart Jan van der Lely, Martin Huisman, Piet Kramer, Richard A Feelders, Patric J D Delhanty and Wouter W de Herder

) and clinical parameters (age at diagnosis, sex, primary tumor location, carcinoid syndrome, ENETS TNM classification ( 32 , 33 ), Ki-67 proliferation index, grading, prior incomplete surgery) in NET patients. Subjects and methods NET

Open access

Ashley K Clift, Oskar Kornasiewicz, Panagiotis Drymousis, Omar Faiz, Harpreet S Wasan, James M Kinross, Thomas Cecil and Andrea Frilling

Introduction Initially termed ‘goblet cell carcinoids’ ( 1 ), goblet cell carcinomas (GCC) are a rare sub-type of neoplasm arising from the appendix, accounting for less than 14% of all appendiceal tumours ( 2 ). Whilst an ‘intermediate

Open access

Majunath R Goroshi, Swati S Jadhav, Anurag R Lila, Rajeev Kasaliwal, Shruti Khare, Chaitanya G Yerawar, Priya Hira, Uday Phadke, Hina Shah, Vikram R Lele, Gaurav Malhotra, Tushar Bandgar and Nalini S Shah

small-cell carcinoma of lung), majority of cases of EAS are now reported to be caused by neuroendocrine tumours (NETs) that include carcinoid tumours of bronchopulmonary system, thymus, and gastrointestinal tract; pancreatic NETs; medullary thyroid

Open access

E T Aristizabal Prada and C J Auernhammer

are the small intestinal cell lines P-STS, L-STS and H-STS ( 30 ) and the neuroendocrine carcinoma cell lines NEC-DUE1, NEC-DUE2 ( 31 ) and N-TAK1 ( 32 ). Whole-exome characterisation of human pancreatic NET cell lines BON1 and QGP1 and human carcinoid

Open access

Giulia Bresciani, Angeliki Ditsiou, Chiara Cilibrasi, Viviana Vella, Federico Rea, Marco Schiavon, Narciso Giorgio Cavallesco, Georgios Giamas, Maria Chiara Zatelli and Teresa Gagliano

management of BP-NENs ( 11 ). Chemotherapy and radiation have already been demonstrated to be ineffective in the treatment of BP-NENs, while somatostatin analogues have shown a great effect in controlling the eventual secretory pattern of carcinoids but not